Health Discovery Corp (HDVY)

[JustGarden]

News brief 12/17/2012 for NeoGenomics from PRNewswire @7:00am


Dr. Maher Albitar, the Company's Chief Medical Officer and Director of Research and Development, commented, "Improving surveillance in BE patients results in better and potentially earlier treatment for those patients who are likely to progress to esophageal cancer. Our unique approach of performing FISH testing on brushing samples provides a reliable and an objective means of detecting high grade dysplasia and cancer. We believe it will enable a major step forward in BE surveillance programs as it allows clinicians to more easily and frequently tests their BE patients and track quantitative findings over the monitoring period."

How many other HDVY board members have migrated to NEO? And for what reason?